Seres Therapeutics, Inc.
MCRBNasdaqHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $789,000 | $0 | $0 | $7.1M | $143.9M | $11.9M |
| Operating income | −$94.0M | −$121.3M | −$195.1M | −$179.9M | −$64.5M | −$88.1M |
| Net income | $5.7M | $136,000 | −$113.7M | −$250.2M | −$65.6M | −$89.1M |
| Total assets | $138.2M | $139.8M | $358.6M | $348.8M | $354.9M | $342.9M |
| Total liabilities | $94.0M | $126.0M | $403.5M | $338.0M | $223.4M | $168.2M |
| Equity | $44.2M | $13.8M | −$44.9M | $10.8M | $131.5M | $174.8M |
| EPS (diluted) | $0.64 | $0.00 | $-17.77 | $-2.31 | $-0.72 | $-1.12 |
| Shares out. | 174.4M | 151.0M | 126.1M | 92.0M | 91.5M | 71.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −11910.1%
- Net margin
- 721.9%
- Return on equity
- 12.9%
- Return on assets
- 4.1%
- Return on capital (ROCE)
- −79.1%
- Liabilities / assets
- 68.0%
- Debt / equity
- 2.13×
- Book value / share
- $0.25
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- 4088.2%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -25.59distress
- Accruals / assets
- 3.3%clean
- Piotroski F-Score
- 6/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 1 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Fmr LlcPassive (13G)Aug 6, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 512,802 | 11.1 | -5.2% |
| Apr 30, 2026 | 540,750 | 8.8 | -7.6% |
| Apr 15, 2026 | 585,069 | 14.9 | -2.0% |
| Mar 31, 2026 | 597,314 | 12.1 | -5.0% |
| Mar 13, 2026 | 628,417 | 14.3 | -4.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Director / officer changeJun 1, 2026
- Results of operationsMay 5, 2026
- Other material eventMar 16, 2026
- Results of operations · Regulation FD disclosureMar 12, 2026
- Director / officer changeMar 2, 2026
- Results of operations · Regulation FD disclosureNov 5, 2025
- Other material eventOct 3, 2025
- Results of operations · Regulation FD disclosureAug 6, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.